Trial intelligence / Profile preview

Dexmedetomidine vs Lidocaine for Post-Mastectomy Pain

NCT06974656Completed

Sponsor
Cairo University
Start
May 2025
Primary completion
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in acute postoperative pain comparing Dexmedetomidine group with Lidocaine group (2 arms). Primary endpoint: Time to the first rescue analgesia. Started May 2025; status: completed.

02

Drugs

dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on NCT06974656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06974656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call